Efficacy of salvage therapy with MTX-HOPE for elderly patients with heavily pretreated non-Hodgkin’s lymphoma

Methotrexate, hydrocortisone, vincristine, sobuzoxane, and etoposide (MTX-HOPE) chemotherapy was originally reported in 2007 as a salvage regimen for relapsed or refractory non-Hodgkin’s lymphoma. To clarify the safety and efficacy of this regimen, we retrospectively analyzed patients at our institu...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukunaga, Akiko, Okamoto, Yoshio, Shibata, Sho, Inano, Shojiro, Takiuchi, Yoko, Yamamoto, Kazuyo, Tabata, Sumie, Kitano, Toshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JSLRT 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337273/
https://www.ncbi.nlm.nih.gov/pubmed/32404568
http://dx.doi.org/10.3960/jslrt.19029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337273/
https://www.ncbi.nlm.nih.gov/pubmed/32404568
http://dx.doi.org/10.3960/jslrt.19029

Ejemplares similares